(19)
(11) EP 3 445 354 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
06.07.2022 Bulletin 2022/27

(45) Mention of the grant of the patent:
25.05.2022 Bulletin 2022/21

(21) Application number: 17786579.7

(22) Date of filing: 19.04.2017
(51) International Patent Classification (IPC): 
A61K 31/23(2006.01)
A01N 37/06(2006.01)
A61K 47/00(2006.01)
A61P 3/08(2006.01)
 A01N 37/02(2006.01)
A61K 45/06(2006.01)
A61K 9/00(2006.01)
A61P 3/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/23; A61K 9/0019; A61K 9/0053; A61K 45/06; A61P 3/08; A61P 3/10; A61P 43/00
 
C-Sets:
A61K 31/23, A61K 2300/00;
(86) International application number:
PCT/US2017/028417
(87) International publication number:
WO 2017/184767 (26.10.2017 Gazette 2017/43)

(54)

AZELAIC ACID ESTERS IN THE TREATMENT OF INSULIN RESISTANCE

AZELAINSÄUREESTER IN DER BEHANDLUNG VON INSULINRESISTENZ

ESTERS D'ACIDE AZÉLAÏQUE UTILISÉS DANS LE TRAITEMENT D'UNE RÉSISTANCE À L'INSULINE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.04.2016 US 201662325381 P

(43) Date of publication of application:
27.02.2019 Bulletin 2019/09

(60) Divisional application:
22175016.9

(73) Proprietor: New Frontier Labs, LLC
San Antonio, TX 78209-1403 (US)

(72) Inventors:
  • STREEPER, Robert T.
    San Antonio Texas 78240 (US)
  • IZBICKA, Elzbieta
    San Antonio Texas 78240 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstrasse 3
81675 München
81675 München (DE)


(56) References cited: : 
WO-A1-2010/005521
KR-B1- 101 593 539
 WO-A1-2013/158541
   
  • MUTHULAKSHMI, S ET AL.: 'Gene expression profile of high-fat diet-fed C57BU6J mice: in search of potential role of azelaic acid' JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY vol. 71, no. 1, March 2015, pages 29 - 42, XP035454906
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).